{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:03:10Z","timestamp":1780909390205,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ahj.2025.09.006","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T02:22:44Z","timestamp":1757643764000},"page":"107274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design and rationale of aspirin versus aspirin and fondaparinux prior to early invasive strategy in patients with NSTEMI: The FOXY trial"],"prefix":"10.1016","volume":"292","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7335-4911","authenticated-orcid":false,"given":"Christian Byskov","family":"Fur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels Thue","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Flensted","family":"Lassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashkan","family":"Eftekhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Stengaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Kj\u00e6r","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B\u00f8hme","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Juhl","family":"Terkelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.ahj.2025.09.006_bib0001","first-page":"e344","article-title":"2014 AHA\/ACC Guideline for the Management of Patients With Non\u2013ST-Elevation Acute Coronary Syndromes","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"issue":"38","key":"10.1016\/j.ahj.2025.09.006_bib0002","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.ahj.2025.09.006_bib0003","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","article-title":"Aspirin, heparin, or both to treat acute unstable angina","volume":"319","author":"Th\u00e9roux","year":"1988","journal-title":"N Engl J Med"},{"issue":"8719","key":"10.1016\/j.ahj.2025.09.006_bib0004","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)92336-G","article-title":"Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group","volume":"336","year":"1990","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.ahj.2025.09.006_bib0005","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0002-9149(90)91155-Y","article-title":"Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the antithrombotic therapy in acute coronary syndromes study group)","volume":"66","author":"Cohen","year":"1990","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2025.09.006_bib0006","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.89.1.81","article-title":"Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group","volume":"89","author":"Cohen","year":"1994","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ahj.2025.09.006_bib0007","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0735-1097(94)90539-8","article-title":"Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina","volume":"24","author":"Holdright","year":"1994","journal-title":"J Am College Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2025.09.006_bib0008","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0735-1097(95)80001-W","article-title":"Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia","volume":"26","author":"Gurfinkel","year":"1995","journal-title":"J Am College Cardiol"},{"issue":"9001","key":"10.1016\/j.ahj.2025.09.006_bib0009","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(96)91270-2","article-title":"Fragmin during Instability in Coronary Artery Disease (FRISC) study group. Low-molecular-weight heparin during instability in coronary artery disease","volume":"347","year":"1996","journal-title":"The Lancet"},{"issue":"9219","key":"10.1016\/j.ahj.2025.09.006_bib0010","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0140-6736(00)02324-2","article-title":"Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis","volume":"355","author":"Eikelboom","year":"2000","journal-title":"The Lancet"},{"key":"10.1016\/j.ahj.2025.09.006_bib0011","unstructured":"Dansk Hjerteregister. Dansk Hjerteregister - \u00c5rsrapport 2022 [Internet]. Regionernes Kliniske Kvalitetsudviklingsprogram; 2023. Available from: https:\/\/www.sundk.dk\/media\/tvie5zir\/9b4384e08ebb4c7cbc2c2999bdefd1e8.pdf."},{"issue":"9180","key":"10.1016\/j.ahj.2025.09.006_bib0012","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0140-6736(99)07349-3","article-title":"Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study","volume":"354","year":"1999","journal-title":"The Lancet"},{"issue":"14","key":"10.1016\/j.ahj.2025.09.006_bib0013","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Comparison of fondaparinux and enoxaparin in acute coronary syndromes","volume":"354","year":"2006","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.ahj.2025.09.006_bib0014","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ahj.2025.09.006_bib0015","first-page":"19","article-title":"Noninferiority trials","volume":"1","author":"Snapinn","year":"2000","journal-title":"Curr Control Trials Cardiovasc Med"},{"issue":"11","key":"10.1016\/j.ahj.2025.09.006_bib0016","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3345\/kjp.2012.55.11.403","article-title":"Understanding noninferiority trials","volume":"55","author":"Hahn","year":"2012","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.ahj.2025.09.006_bib0017","unstructured":"U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. Non-Inferiority Clinical Trials to Establish Effectiveness. Silver Spring, MD; 2016. Available from: https:\/\/www.fda.gov\/media\/78504\/download."}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870325003278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870325003278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:20:06Z","timestamp":1780906806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870325003278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":17,"alternative-id":["S0002870325003278"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2025.09.006","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and rationale of aspirin versus aspirin and fondaparinux prior to early invasive strategy in patients with NSTEMI: The FOXY trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2025.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107274"}}